Press Releases

SOLCO HEALTHCARE US, RECEIVES FDA APPROVAL FOR GLYCOPYRROLATE INJECTION, 0.2 mg/mL

Mar 08, 2019 04:21

March 8, 2018 SOLCO HEALTHCARE US, RECEIVES FDA APPROVAL FOR GLYCOPYRROLATE INJECTION, 0.2 mg/mL CRANBURY, NJ -- Solco Healthcare announces its FDA approval for Glycopyrrolate Injection, 0.2mg/mL, which is an...

Read more

SOLCO HEALTHCARE US ANNOUNCES THE FDA APPROVAL OF FENOFIBRATE TABLETS, 48mg and 145mg

Mar 08, 2019 04:05

CRANBURY, NJ -- Solco Healthcare is proud to announce its FDA approval for Fenofibrate tablets, 48 mg and 145 mg, which is an AB-rated equivalent to Tricor® by Abbvie. Fenofibrate...

Read more

Manager/Senior Manager, Order to Cash

Feb 27, 2019 15:51

COMPANY BACKGROUND Solco Healthcare U.S., headquartered in Cranbury, New Jersey, is an industry leader in marketing and distributing generic pharmaceuticals. Solco is committed to providing our customers with high...

Read more

Press Release - Dec. 14, 2018

Dec 14, 2018 19:43

FOR IMMEDIATE RELEASE – CRANBURY, NEW JERSEY -  December 14, 2018 On July 12, 2018, Prinston Pharmaceutical Inc. announced that one of its affiliated companies, Solco Healthcare, LLC, based in...

Read more

Press Release – Update on Valsartan API – A Statement from the Company

Aug 21, 2018 15:20

FOR IMMEDIATE RELEASE - CRANBURY, NEW JERSEY, August 21, 2018. Huahai US Inc., a subsidiary of Zhejiang Huahai Pharmaceutical Co. Ltd is issuing a statement. Recent articles in several print...

Read more

SOLCO HEALTHCARE US ANNOUNCES THE LAUNCH OF ENTECAVIR TABLETS

Apr 25, 2018 17:09

CRANBURY, NJ., April 25, 2018 – Solco Healthcare is proud to announce the launch of Entecavir Tablets, 0.5mg and 1mg, a generic equivalent of Baraclude® Tablets by Bristol-Myers Squibb Company. ...

Read more

SOLCO HEALTHCARE US ANNOUNCES THE LAUNCH OF CLONIDINE HCL ER TABLETS

Apr 03, 2018 17:35

Cranbury, NJ., April 3, 2018.  Solco Healthcare announced today the launch of Clonidine Hydrochloride Extended-Release Tablets, 01.mg, a generic version of Kapvay® Tablets by Concordia Pharmaceuticals Inc.  The product is...

Read more

Solco Healthcare US receives FDA approval for its generic to Abilify® tablets

Mar 01, 2018 19:52

CRANBURY, NJ – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Abilify® Tablets (Aripiprazole tablets), 2, 5, 10...

Read more

Solco Healthcare US Announces the FDA Approval for its generic to Hyzaar® Tablets

Feb 28, 2018 22:02

CRANBURY, NJ – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Hyzaar® Tablets (Losartan Potassium and Hydrochlorothiazide tablets)...

Read more

Solco Healthcare US Announces the Approval of Generic Cymbalta® Capsules

Aug 21, 2017 15:10

CRANBURY, NJ – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Cymbalta® Capsules (Duloxetine delayed-release capsules), 20mg, 30mg...

Read more

Solco Healthcare US Receives FDA Approval for Telmisartan Tablets, 20mg, 40mg and 80mg.

Jun 08, 2017 00:00

CRANBURY, NJ -- Solco Healthcare is proud to announce its FDA approval for Telmisartan tablets, 20mg, 40mg and 80mg, which are AB-rated equivalents to Micardis® by Boehringer Ingelheim. “This recent...

Read more

SOLCO HEALTHCARE INTRODUCES OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE Tablets

Apr 24, 2017 00:00

CRANBURY, NJ -- Solco Healthcare today announced the launch of generic version of Daiichi-Sankyo’s Benicar-HCT®, Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 20mg/12.5mg, 40/12.5mg and 40mg/25mg.  Solco received its final approval by...

Read more

SOLCO HEALTHCARE US, INTRODUCES DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS, 150mg and 200mg

Nov 15, 2016 16:20

CRANBURY, NJ -- Solco Healthcare is proud to announce its FDA approval for Doxycycline Hyclate delayed-release tablets, 150mg and 200mg, which are AB-rated equivalents to Doryx® by Mayne Pharmaceutical. “This...

Read more

SOLCO HEALTHCARE U.S. ANNOUNCES THE APPROVAL OF GENERIC VFEND ® TABLETS IN THE UNITED STATES

Aug 12, 2016 10:59

CRANBURY, NJ – August 11, 2016 – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Vfend ® Tablets...

Read more

Solco News

Here you will find useful healthcare related information and latest industry news, including exclusive content available only on Solco News.


Archives

2019 2018 2017 2016